Janus Henderson Group PLC Solid Biosciences Inc. Transaction History

Janus Henderson Group PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$7.19 - $32.37 $2.68 Million - $12.1 Million	-372,905 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$21.32 - $46.34 $3.02 Million - $6.57 Million	-141,884 Reduced 27.56%	372,905 $9.99 Million
Q3 2018 Nov 09, 2018	BUY	$36.35 - $51.7 $18.7 Million - $26.6 Million	514,789 New	514,789 $24.3 Million

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $38.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.